Foxconn is deploying physical AI robots directly into hospital workflows, moving beyond prototypes into real clinical environments where they're already reducing nursing workload by approximately 30% and handling dozens of daily tasks. The manufacturing giant unveiled its comprehensive healthcare AI vision at COMPUTEX 2026 and NVIDIA GTC Taipei, showcasing how embodied AI systems, digital twins, and collaborative robots are beginning to transform hospital operations across Taiwan.

What Exactly Are These Hospital Robots Doing?

Foxconn's Nurabot, a nursing collaborative robot, has completed field validation and is now progressively expanding into hospitals and long-term care environments, including Taipei Veterans General Hospital and Tungs' Taichung MetroHarbor Hospital. Real-world deployment data shows the robot can execute 75 to 80 tasks daily, handling medication delivery, specimen transport, and other clinical assistance workflows that traditionally consume nursing staff time.

Beyond basic delivery tasks, Foxconn is developing more specialized systems. The company jointly created a scrub nurse collaborative robot with Kawasaki Heavy Industries, Taichung Veterans General Hospital, and Yuan High-Tech. This system uses advanced vision and language processing to understand surgical scenes and reason about intelligent task execution inside operating rooms, with clinical validation planned to accelerate development.

Perhaps most ambitious is Foxconn's integrated chemotherapy drug compounding and delivery system, developed with Taipei Veterans General Hospital, Kawasaki Heavy Industries, Yuyama Manufacturing, and FARobot. This platform creates a closed-loop workflow where one robot performs high-precision chemotherapy drug compounding, another autonomously transports medications within the hospital, and Nurabot supports final delivery to nursing stations and patients.

How Is Foxconn Building These AI Hospital Systems?

• Full-Stack AI Architecture: Foxconn leverages NVIDIA's five-layer framework spanning energy, infrastructure, platform, models, and applications to create AI-native healthcare infrastructure capable of supporting increasingly autonomous clinical operations.
• Digital Twin Simulation: The company uses NVIDIA Omniverse to create virtual-physical integrated healthcare environments where robots can be trained and validated before real-world deployment, reducing risk and accelerating development cycles.
• Multi-Agent Orchestration: Foxconn developed CoDoClaw, a clinical intelligent agent system built on NVIDIA NemoClaw that coordinates multiple AI agents across breast cancer screening, ECG analysis, fundus imaging, and coronary artery analysis through a unified clinical interface.
• Embodied Intelligence Integration: Rather than developing isolated AI tools, Foxconn is integrating AI systems capable of perceiving, reasoning, and acting alongside healthcare professionals across entire hospital environments.

The CoDoClaw system represents a significant shift in how hospitals might operate. By connecting AI-driven lesion detection, appointment scheduling, report generation, and follow-up management, the platform demonstrates how clinical AI agents can progressively support cross-department workflow orchestration and future healthcare automation.

"Healthcare's next transformation will not come from AI models alone, but from AI systems capable of perceiving, reasoning and acting in real-world clinical environments alongside healthcare professionals," said Barry Chiang, President of Foxconn B Group and Digital Health.

Barry Chiang, President of Foxconn B Group and Digital Health

Why Is Taiwan Becoming a Physical AI Healthcare Hub?

Taiwan offers unique structural advantages for advancing physical AI in healthcare. The country combines world-class healthcare and national insurance systems, global leadership in semiconductors and AI infrastructure, and highly integrated clinical environments that provide ideal real-world validation grounds. Taiwan's digitized healthcare ecosystem creates a natural laboratory for testing and refining AI-powered hospital systems at scale.

This positioning matters because physical AI in healthcare isn't just about individual robots; it's about creating interconnected systems that can coordinate across entire hospital workflows. Foxconn's vision extends beyond Taiwan, with the company working through the Taiwan Digital Health Alliance (HiMEDt) to accelerate physical AI deployment across hospitals, long-term care, and home healthcare environments, helping position Taiwan as a global showcase for next-generation smart healthcare transformation.

The convergence of aging populations, workforce shortages, and growing clinical complexity creates urgent demand for these systems. Healthcare systems worldwide are confronting staffing challenges that physical AI robots can begin to address, not by replacing healthcare workers but by handling repetitive, physically demanding tasks that consume time and energy.

What's the Practical Impact on Hospital Operations?

The 30% reduction in nursing workload represents a meaningful shift in how hospitals allocate human resources. When Nurabot handles medication delivery and specimen transport, nursing staff can focus on patient interaction, clinical decision-making, and care quality. The chemotherapy drug compounding system improves medication safety and traceability in high-risk environments where precision is critical and errors carry serious consequences.

What distinguishes Foxconn's approach from earlier robotics efforts is the emphasis on workflow integration rather than isolated automation. The company isn't deploying robots to perform single tasks; it's building orchestrated systems where multiple robots, AI agents, and human staff coordinate through shared operational intelligence. This requires not just better robots but better software architecture, simulation platforms, and clinical validation processes.

The timeline for broader adoption remains uncertain, but the fact that these systems are already operating in major hospitals suggests the technology is moving from research phase into practical deployment. Future clinical validation of the scrub nurse robot in operating rooms and continued expansion of Nurabot into additional hospitals will provide clearer evidence of whether physical AI can deliver on its healthcare promise at scale.